Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Massachusetts Healthcare Journal.
Press releases published on September 17, 2025
September 17, 2025
Parents Forum Brings Free Communication Workshop to Harvard Square Community
Indeterminate
EIN Presswire
September 17, 2025
Stannah Stairlifts Reaches Trustpilot Milestone, Celebrating 1,000 Customer Reviews
Indeterminate
EIN Presswire
September 17, 2025
Parents Forum Hosts In-Person Communication Training for Prospective Volunteers
Indeterminate
EIN Presswire
September 17, 2025
Parents Forum Offers Free Online Workshop for Better Family Communication
Indeterminate
EIN Presswire
September 17, 2025
OSSIOfiber® Revolutionizes Orthopedic Surgery with Bio-Integrative Implants, Leaving Only Natural Bone Behind
Indeterminate
EIN Presswire
September 17, 2025
The Choroideremia Research Foundation (CRF) Marks 25 Years of Progress, Research, and Community Support
Indeterminate
EIN Presswire
September 17, 2025
Northeast Health Services Opens New Mental Health Clinic in Salem, Massachusetts
Indeterminate
EIN Presswire
September 17, 2025
MtoZ Biolabs Launches PRM Quantitative Proteomics: Empowering Precision in Scientific Research
Indeterminate
EIN Presswire
September 17, 2025
Advancing Precision Epigenetic Research: MtoZ Biolabs Characterizes Histone Post-Translational Modifications Using MS
Indeterminate
EIN Presswire
September 17, 2025
Bionano Genomics, Inc. Announces Closing of $10 Million Public Offering
Indeterminate
GlobeNewswire
September 17, 2025
Arvinas Provides Update on Collaboration with Pfizer and Announces Further Actions to Support Value Creation
Indeterminate
GlobeNewswire
September 17, 2025
Vor Bio Announces Oral Presentation of 48-Week China Phase 3 Generalized Myasthenia Gravis Clinical Study at AANEM
Indeterminate
GlobeNewswire
September 17, 2025
CooperCompanies Announces Expanded Share Repurchase Program
Indeterminate
GlobeNewswire
September 17, 2025
Regional Health Properties, Inc. Completes Repurchases of 12.5% Series B Cumulative Redeemable Preferred Shares
Indeterminate
GlobeNewswire
September 17, 2025
Vaxart Appoints W. Mark Watson as Lead Independent Director
Indeterminate
GlobeNewswire